Patents by Inventor Matthew Collin Thor Fyfe

Matthew Collin Thor Fyfe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lysine demethylase inhibitors for diseases and disorders associated with Flaviviridae
    Patent number: 9790196
    Abstract: The invention relates to methods and compositions for the treatment or prevention of Flaviviridae infections. In particular, the invention relates to an LSD1 inhibitor for use in treating or preventing Flaviviridae infections, including hepatitis C virus infections.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: October 17, 2017
    Assignee: ORYZON GENOMICS S.A.
    Inventors: Jonathan A. Baker, Matthew Collin Thor Fyfe
  • LYSINE DEMETHYLASE INHIBITORS FOR DISEASES AND DISORDERS ASSOCIATED WITH FLAVIVIRIDAE
    Publication number: 20140256742
    Abstract: The invention relates to methods and compositions for the treatment or prevention of Flaviviridae infections. In particular, the invention relates to an LSD1 inhibitor for use in treating or preventing Flaviviridae infections, including hepatitis C virus infections.
    Type: Application
    Filed: December 4, 2013
    Publication date: September 11, 2014
    Inventors: Jonathan A. BAKER, Matthew Collin Thor Fyfe